European CEP (Certificate of Suitability) Application & EDQM Deficiency Response Guide
Detailed guide to European CEP applications to EDQM, CTD dossier preparation, mutagenic impurities disclosures, and technical responses to official deficiency letters.
A CEP (Certificate of Suitability) is issued by EDQM, verifying that an API’s quality is controlled by the European Pharmacopoeia (Ph. Eur.) monograph. The applicant must prove that the monograph monograph is sufficient to control all impurities (including those not mentioned in the monograph but possible from the synthesis). Otherwise, additional testing methods must be proposed.
Handling Impurities Not Listed in the Ph. Eur. Monograph
If the manufacturing process introduces unique impurities not listed in the Ph. Eur. monograph, EDQM reviews elution behavior. If they co-elute or exceed default thresholds, a new specific analytical method and limit must be validated and proposed.
- Verifying if non-listed impurities can be separated and quantified by current Ph. Eur. methods
- Conducting toxicological hazard reviews (structural alerts, QSAR modeling)
- Proposing supplementary analytical conditions and limits on the draft CEP certificate
FAQ
Where is the CEP certificate accepted?+
The CEP is accepted across all 27 EU member states, as well as by all contracting states of the European Pharmacopoeia Convention (including Switzerland, the UK, Turkey, Canada, and parts of Africa/Middle East).
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
